Research Paper Volume 16, Issue 13 pp 10813—10831
An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer
Figure 3. Prognostic value and functional analysis of WDHD1 in BLCA. (A) Prognostic modeling assays. (B) Time-dependent ROC analysis curves for 1-, 3-, and 5-year OS characteristics of WDHD1 (C, D) Nomogram and ROC curves for predicting the 1-, 3-, and 5-year OS of BLCA patients in the entire cohort. (E) GO and KEGG of WDHD1. (F) GSEA analysis of the correlation between DEGs of WDHD1 and function pathways. (G) Invasion and migration assay, knockdown of WDHD1 expression reduces invasion and migration ability.